CompletedNot Applicable

Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback

United States39 participantsStarted 2018-06-01

Plain-language summary

Patients with vocal hyperfunction will undergo standard of care voice therapy with ambulatory voice monitoring before therapy and after the first 3 voice therapy sessions. Biofeedback will be added to ambulatory monitoring after the 2nd voice therapy session only.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with vocal fold nodules or muscle tension dysphonia undergoing voice therapy Exclusion Criteria: * If a patient's baseline ambulatory monitoring data is not at least 1 standard deviation away from a normative database in any measure, he/she will be excluded. Non-English speakers are excluded because prompts on the smartphone app are only available in English.

What they're measuring

Percent Compliance

Timeframe: Week 1, Week 2, Week 3

Trial details

NCT IDNCT03416868

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-25

Results submitted2024-02-13

View on ClinicalTrials.gov More Vocal Fold Nodules trials